Silco Pharmaceuticals Q3 earnings rise 3%

Silco Pharmaceuticals Limited has posted a 3 per cent rise in its earnings for the third quarter (January-March) of the year 2021-2022.

Its earnings per share (EPS) stood at Tk 0.33 in the January-March period from Tk 0.32 recorded in the same period a year ago, the company said in a filing with the Dhaka Stock Exchange (DSE) on Tuesday.

Its net operating cash flow per share turned positive (Tk 1.31) in the first nine months of the current fiscal year. It was Tk 1.79 in the Q3 of the previous year.

The net asset value (NAV) of the company per share was Tk 21.98 as of March 31, 2022, and Tk 21.85 as of June 30, 2021.

The share price of the Silco Pharmaceuticals rose by 2.01 per cent to Tk 25.40 on the DSE in the first hour into the trade on Tuesday.

The price moved between Tk 22.10 and Tk 36.10 throughout the last year.

Listed in 2019, the company has Tk 258 crore in market capitalisation, Tk 103 crore in paid-up capital and Tk 123 crore in surplus reserve.